Centinel Spine™ Completes Successful Evaluation of STALIF L™

Minimally-Invasive Lateral Integrated Interbody System

News provided by

Jun 21, 2016, 07:00 ET

NEW YORK, June 21, 2016 /PRNewswire/ -- Centinel Spine, Inc., (Centinel Spine), the pioneer of the No-Profile^®, Integrated Interbody™ fusion device market, completes Alpha release of STALIF L™ No-Profile, lateral lumbar Integrated Interbody device cleared by the U.S. Food and Drug Administration (FDA).

Centinel Spine STALIF L Lateral, Integrated Interbody Technology

STALIF L continues the thirty-year STALIF^® heritage of innovation as STALIF L is the only lateral device to offer the benefits of no-profile, compressive lag fixation with proprietary anti-backout technology and 12-degrees of lordosis. "STALIF L exemplifies our continued commitment to being the gold standard in Integrated Interbody devices," said John J. Viscogliosi, Chairman & CEO, Centinel Spine. "We are excited to bring the STALIF advantage to minimally-invasive spinal fusion surgery," Mr. Viscogliosi continued.

In addition to the above-mentioned STALIF benefits, STALIF L also offers a large chamber for bone graft to support fusion, optimized fixation with easily placed self-drilling, self-tapping screws and a variety of cage sizes to match patient anatomy, including a 12-degree lordotic option.

Robert Kimber, MD, Performance Spine Institute, Gulfport, MS, explained, "Over the past year I have used the STALIF L to treat many of my patients in need of minimally-invasive lateral lumbar reconstruction spine surgery. I like the 12 degrees of lordosis and the fixation provided by the screws."

"STALIF L has the unique feature of compressive lag fixation, which assists me in ensuring that the bony endplates compress the device and bone graft, which I believe to be optimum in accordance with Wolff's law," continued Dr. Kimber.

Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C^®, STALIF C-Ti™, MIDLINE II™ and MIDLINE II-Ti™. STALIF C-Ti and MIDLINE II-Ti merge the proven clinical success of STALIF Integrated Interbody technology with Ti-ACTIVE™, a texturized titanium coating developed with over 15 years of science and engineering experience.

Upon the completion of its Alpha release with a variety of minimally-invasive retractor options, Centinel Spine begins to release the STALIF L system to spine surgeons in the United States. For more information on STALIF L, please visit lateral.centinelspine.com.

About Centinel Spine, Inc.
Centinel Spine, Inc. is a privately-held spinal device company leading the development and commercialization of the No-Profile, Integrated Interbody fusion technologies. For more information on Centinel Spine products and technologies, please visit the Company's web site at www.centinelspine.com.

The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generate superior clinical outcomes.

Centinel Spine derived its name from the "Sentinel Sign" – the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please contact:
John Parry
Centinel Spine, Inc.
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484.887.8813
Email: [email protected]

Photo - http://photos.prnewswire.com/prnh/20160620/381085

Logo - http://photos.prnewswire.com/prnh/20160523/370654LOGO

SOURCE Centinel Spine, Inc.